AFLD 2011 FFFA vs Respondent M112

Facts
The French Football Federation (Fédération Française de Football Américain, FFFA) charges respondent M112 for a violation of the Anti-Doping Rules. During a match on February 26, 2011, a sample was taken for doping control purposes. The analysis showed the presence of tuaminoheptane a prohibited substance according the World Anti Doping Agency (WADA) prohibited list. It is regarded as a specified substance.

History
The positive test was the result of medicine the respondent had used to treat nasopharyngitis. He has a prescription for this medicine from his physician.

Decision
1. The sanction is a period of ineligibility of one month in which respondent can't take part in competition or manifestations organized or authorized by the FFFA.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
17 November 2011
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
American Football (IFAF) - International Federation of American Football
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Football Américain (FFFA) - French Federation of American Football
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S6. Stimulants
Substances
Tuaminoheptane
Medical terms
Treatment / self-medication
Document type
Pdf file
Date generated
15 April 2014
Date of last modification
4 July 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin